Kelly T Gleason1, Saman Nazarian, Cheryl R Dennison Himmelfarb. 1. Kelly T. Gleason, RN, BSN Doctoral Candidate, School of Nursing, Johns Hopkins University, Baltimore, Maryland. Saman Nazarian, MD, PhD Associate Professor, School of Medicine, University of Pennsylvania, Philadelphia, and School of Medicine, Johns Hopkins University, Baltimore, Maryland. Cheryl R. Dennison Himmelfarb, RN, ANP, PhD, FAHA, FPCNA, FAAN Professor, Schools of Nursing and Medicine, Johns Hopkins University, Baltimore, Maryland.
Abstract
BACKGROUND: Atrial fibrillation (AF) symptoms are a major component of treatment decisions for patients with AF and impact quality of life and functional ability yet are poorly understood. OBJECTIVE: This review aimed to determine what is known about the prevalence of symptoms and the association of symptoms to AF characteristics, psychological distress, sex, and race. METHODS: We performed a structured review of AF symptoms as of March 2016 using PubMed, EMBASE, and CINAHL and reference searches of retrieved articles. Full-text, published, peer-reviewed, English-language articles were examined. Articles were included if they reported original research data on symptom prevalence and type among patients with AF. RESULTS: The 3 most common symptoms were dyspnea, palpitations, and fatigue. The results suggested that, although AF characteristics are not a significant predictor of symptoms, tachycardia, female sex, race, and psychological distress have a positive association to symptoms. CONCLUSIONS: There is a scarcity of research examining symptoms in AF. Furthermore, the inconsistency in measurement methods and the failure to include diverse populations in AF research make it difficult to draw definitive conclusions from the current literature. Given the prevalence of AF in the United States and the impact of symptoms on quality of life and healthcare use, further research examining predictors of symptoms and interventions to alleviate symptoms is crucial.
BACKGROUND:Atrial fibrillation (AF) symptoms are a major component of treatment decisions for patients with AF and impact quality of life and functional ability yet are poorly understood. OBJECTIVE: This review aimed to determine what is known about the prevalence of symptoms and the association of symptoms to AF characteristics, psychological distress, sex, and race. METHODS: We performed a structured review of AF symptoms as of March 2016 using PubMed, EMBASE, and CINAHL and reference searches of retrieved articles. Full-text, published, peer-reviewed, English-language articles were examined. Articles were included if they reported original research data on symptom prevalence and type among patients with AF. RESULTS: The 3 most common symptoms were dyspnea, palpitations, and fatigue. The results suggested that, although AF characteristics are not a significant predictor of symptoms, tachycardia, female sex, race, and psychological distress have a positive association to symptoms. CONCLUSIONS: There is a scarcity of research examining symptoms in AF. Furthermore, the inconsistency in measurement methods and the failure to include diverse populations in AF research make it difficult to draw definitive conclusions from the current literature. Given the prevalence of AF in the United States and the impact of symptoms on quality of life and healthcare use, further research examining predictors of symptoms and interventions to alleviate symptoms is crucial.
Authors: Anil K Gehi; Samuel Sears; Neeta Goli; T Jennifer Walker; Eugene Chung; Jennifer Schwartz; Kathryn A Wood; Kimberly Guise; J Paul Mounsey Journal: J Cardiovasc Electrophysiol Date: 2012-03-19
Authors: P Gabriel Steg; Samir Alam; Chern-En Chiang; Habib Gamra; Marnix Goethals; Hiroshi Inoue; Laura Krapf; Thorsten Lewalter; Ihsen Merioua; Jan Murin; Lisa Naditch-Brûlé; Piotr Ponikowski; Mårten Rosenqvist; José Silva-Cardoso; Oleg Zharinov; Sandrine Brette; James O Neill Journal: Heart Date: 2011-09-22 Impact factor: 5.994
Authors: James V Freeman; DaJuanicia N Simon; Alan S Go; John Spertus; Gregg C Fonarow; Bernard J Gersh; Elaine M Hylek; Peter R Kowey; Kenneth W Mahaffey; Laine E Thomas; Paul Chang; Eric D Peterson; Jonathan P Piccini Journal: Circ Cardiovasc Qual Outcomes Date: 2015-06-09
Authors: Robbert Zusterzeel; Kimberly A Selzman; William E Sanders; Daniel A Caños; Kathryn M O'Callaghan; Jamie L Carpenter; Ileana L Piña; David G Strauss Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: Kimberley L Way; David Birnie; Christopher Blanchard; George Wells; Paul Dorian; Harald T Jorstad; Ioana C Daha; Neville Suskin; Paul Oh; Ratika Parkash; Paul Poirier; Stephanie A Prince; Heather Tulloch; Andrew L Pipe; Harleen Hans; Janet Wilson; Katelyn Comeau; Sol Vidal-Almela; Tasuku Terada; Jennifer L Reed Journal: CJC Open Date: 2022-01-21
Authors: Kelly T Gleason; Cheryl R Dennison Himmelfarb; Daniel E Ford; Harold Lehmann; Laura Samuel; Hae Ra Han; Sandeep K Jain; Gerald V Naccarelli; Vikas Aggarwal; Saman Nazarian Journal: BMC Cardiovasc Disord Date: 2019-04-05 Impact factor: 2.298
Authors: Lauren A Eberly; Lohit Garg; Lin Yang; Timothy M Markman; Ashwin S Nathan; Nwamaka D Eneanya; Sanjay Dixit; Francis E Marchlinski; Peter W Groeneveld; David S Frankel Journal: JAMA Netw Open Date: 2021-02-01
Authors: Monika Sadlonova; Jochen Senges; Jonas Nagel; Christopher Celano; Caroline Klasen-Max; Martin Borggrefe; Ibrahim Akin; Dierk Thomas; Christopher Jan Schwarzbach; Thomas Kleeman; Steffen Schneider; Matthias Hochadel; Tim Süselbeck; Harald Schwacke; Angelika Alonso; Markus Haass; Karl-Heinz Ladwig; Christoph Herrmann-Lingen Journal: J Clin Med Date: 2022-02-21 Impact factor: 4.241
Authors: Nicole Hanna-Rivero; Samuel J Tu; Adrian D Elliott; Bradley M Pitman; Celine Gallagher; Dennis H Lau; Prashanthan Sanders; Christopher X Wong Journal: BMC Cardiovasc Disord Date: 2022-05-04 Impact factor: 2.174